Get a whiff of this: Sony device measuring sense of smell may help diagnose Parkinson’s, dementia
A man measures his sense of smell using a device developed by Sony Corp. in Minato Ward, Tokyo.
13:36 JST, October 18, 2022
Sony Corp. will begin selling a device to medical and research institutions in spring next year that can measure an individual’s sense of smell by emitting 40 different odors.
Since the device makes olfactory measurement easy, it is expected to be useful in the early detection of Parkinson’s disease and dementia. A person’s sense of smell is believed to decline due to both diseases.
The device, which measures about 40 centimeters in length and width, emits five types of odors, including sweet and stinky, at eight different strength levels through a hole in the top.
People sniff these odors and select what they think they smelled on a tablet. The device is expected to be sold for around ¥2.3 million.
According to Sony, conventional olfactory measurement requires a special environment equipped with deodorizing functions to prevent odor leaks affecting the test. Thanks to built-in technology to control air flow, however, the new device enables smells to be easily controlled.
Top Articles in Business
-
Nippon Life Insurance’s U.S. Arm Sues OpenAI Over Legal Assistance Provided by ChatGPT
-
Japan, U.S. Name 3 Inaugural Investment Projects; Reached Agreement After Considerable Difficulty
-
Japan’s Major Real Estate Firms Expanding Overseas Businesses to Secure Future Growth, Focusing on Europe, U.S., Asia
-
JR Tokai Breaks Ground on Yamanashi Maglev Station; Will Be Part of Linear Chuo Shinkansen Line from Tokyo to Nagoya
-
Transport Companies See Opportunity in Narita Expansion; Airlines, Railways Prepare to Meet Expected Growth in Demand
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

